Overview
Kent Mouw is a Radiation Oncologist in Boston, Massachusetts. Dr. Mouw is highly rated in 7 conditions, according to our data. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), Prostatectomy, and Orchiectomy.
His clinical research consists of co-authoring 129 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
75 Francis Street, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Brian Alexander is a Radiation Oncologist in Boston, Massachusetts. Dr. Alexander is highly rated in 19 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is highly rated in 17 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is highly rated in 14 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Muscle Invasive Bladder CancerDr. Mouw isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Mouw isDistinguished. Learn about Prostate Cancer.
- Advanced
- Anal CancerDr. Mouw isAdvanced. Learn about Anal Cancer.
- Familial Prostate CancerDr. Mouw isAdvanced. Learn about Familial Prostate Cancer.
- Non-Muscle Invasive Bladder Cancer
- RetinoblastomaDr. Mouw isAdvanced. Learn about Retinoblastoma.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- Ataxia-TelangiectasiaDr. Mouw isExperienced. Learn about Ataxia-Telangiectasia.
- Breast CancerDr. Mouw isExperienced. Learn about Breast Cancer.
- Gliomatosis CerebriDr. Mouw isExperienced. Learn about Gliomatosis Cerebri.
- OrchiectomyDr. Mouw isExperienced. Learn about Orchiectomy.
- ProstatectomyDr. Mouw isExperienced. Learn about Prostatectomy.